weight loss response to semaglutide in postmenopausal women this study, who were taking HRT with lost 30% more than women who were not on HRT. #menopause #weightloss #perimenopause #pauselife #womenover40 #womenshealth Postmenopausal women on the GLP-1
Description
These medications are not on the FDA's official medication deferral list for plasma donation
refer to the batch certificate of analysis for lot-specific shelf life data Short-term (lyophilized) : 28 C acceptable for shorter storage periods Post-reconstitution : Refrigerate at 28 C and use within the timeframe specified by the research protocol or product documentation Protect from light, heat, and moisture at all times

If your goal is weight loss and your BCBS plan does have coverage for anti-obesity medications, they will almost certainly direct you toward Wegovy or Zepbound, not Ozempic

Medication is prescribed at provider discretion and is one possible component of a larger protocol

Jones MT, Mahler H christian, Yadav S, et al
